Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
ins
Clinical Update
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
